KCT0009357进行中(未招募)Unknown
Safety and Effectiveness of pravastatin in Korean patients with dyslipidemia based on the cardiovascular risk classification: Pooled analysis of 4 observational studies
Daiichi-Sankyo Korea0 个研究点目标入组 15,475 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 15,475
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18(Year) 至 o Limit(—)
- 性别
- All
入选标准
- •1. Males or females aged = 65 years with a diagnosis of dyslipidemia
- •2. Patients who were prescribed Mevalotin® in the judgment of their physicians, or who started receiving Mevalotin® tab. within 6 weeks from enrollment in this observational study
- •3. Voluntary written consent to participation in this observational study by the patients or their representatives
排除标准
- •1. Subjects who were enrolled even though they violated the prior study's inclusion/exclusion criteria
- •2. Subjects who took another statin drug before participating in prior studies.
- •3. Subjects who took pravastatin 5 mg or 10 mg
研究者
相似试验
已完成
不适用
The Effectiveness and safety of Korean Medicine Treatment after Musculoskeletal Disorder Surgery : Retrospective studyDiseases of the musculo-skeletal system and connective tissueKCT0005121Kyung Hee University Oriental Medical Center300
已完成
不适用
Validation and clinical utility of the Korean version of the Obstetric Quality-of-Recovery score(ObsQoR-11) following elective cesarean section : a prospective observational cohort studyKCT0005794Samsung Medical Center120
招募中
不适用
Efficacy and Safety of Ojeok-san on Korean Patients With Cold Hypersensitivity in the Hands and feet (OJS)Symptoms, signs and abnormal clinical and laboratory findings, NECKCT0002301Gachon University60
已完成
不适用
Efficacy and Safety of Pitavastatin in a Real-world SettingHypercholesterolemiaNCT04402112JW Pharmaceutical28,343
未知
不适用
Kyushu pitavastatin and pravastatin Intervention trial on Diabetic NEphropathYType 2 diabetic nephropathy with HypercholesterolemiaJPRN-UMIN000001324Kyushu University Graduate School of Medical Science Department of Medicine and Bioregulatory Science100
